4//SEC Filing
ACELRX PHARMACEUTICALS INC 4
Accession 0001181431-14-005573
$TLPHCIK 0001427925operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:25 PM ET
Size
5.6 KB
Accession
0001181431-14-005573
Insider Transaction Report
Form 4
Chung David
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-02-04+25,000→ 25,000 totalExercise: $10.34From: 2015-02-04Exp: 2024-02-03→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Issued pursuant to the 2011 Equity Incentive Plan.
- [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 4, 2014) and the remaining shares subject to the option vest on an equal monthly basis over the next 36 months.
- [F3]Double Trigger Acceleration upon Change of Control.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001427925
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 5:25 PM ET
- Size
- 5.6 KB